Valeritas Holdings (Valeritas Holdings) Cyclically Adjusted PS Ratio : (As of May. 08, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Valeritas Holdings Cyclically Adjusted PS Ratio?

Valeritas Holdings does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation

Valeritas Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Valeritas Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeritas Holdings Cyclically Adjusted PS Ratio Chart

Valeritas Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Cyclically Adjusted PS Ratio

Valeritas Holdings Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Valeritas Holdings's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Valeritas Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeritas Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Valeritas Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Valeritas Holdings's Cyclically Adjusted PS Ratio falls into.

Valeritas Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Valeritas Holdings does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Valeritas Holdings (OTCPK:VLRXQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Valeritas Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Valeritas Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeritas Holdings (Valeritas Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Valeritas Holdings Inc (OTCPK:VLRXQ) » Definitions » Cyclically Adjusted PS Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

750 Route 202 South, Suite 600, Bridgewater, NJ, USA, 08807

Website

https://www.valeritas.com

Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insulin delivery device that a patient wears on his or her skin every 24 hours. It commenced commercial sales of V-Go first in the US and has a sales footprint spread across the country. The company primarily generates its revenues in the United States.

Executives

Armistice Capital, Llc	10 percent owner	510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Armistice Capital Master Fund Ltd.	10 percent owner	C/O ARMISTICE CAPITAL, LLC, 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Steven Boyd	10 percent owner	510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Cr Group L.p.	10 percent owner	1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Joseph M Mandato	director	765 MARKET STREET SUITE 290, SAN FRANCISCO CA 941003
Peter Devlin	director	65 WALNUT AVENUE, ANDOVER MA 01810
Brian K Roberts	director	DIGITAS INC.,, 800 BOYLSTON STREET, BOSTON MA 02199
Erick Lucera	officer: See Remarks	138 THISTLE ROAD, NORTH ANDOVER MA 08145
Geoffrey Jenkins	officer: See Remarks	C/O UV SOLUTIONS, 15 GLENBROOK RD, WELLESLEY HILLS MA 02461